The deal is 'an important commercial step' for Limaca to push through a wider clinical rollout of Precision-GI, says ...
TipRanks on MSN
Trendlines’ portfolio firm Limaca strikes exclusive US distribution deal for Precision-GI biopsy system
Trendlines Group ( ($SG:42T) ) has issued an update. Trendlines Group announced that its portfolio company Limaca Medical has signed an exclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback